Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

These medications for BPH have known risks and may have new side effects.

PDGF signaling is crucial for cell development, wound healing, and fluid regulation in the body.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

GI197111X is best dissolved in Capmul MCM for trials.

Yuperio combined with bisoprolol improves heart function in patients with dilated cardiomyopathy.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

Prostaglandin helps regenerate hair follicles after radiation damage.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Polydeoxyribonucleotide (PDRN) may help lighten skin and treat hyperpigmentation.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Finasteride reduces movement issues in Parkinson's disease rats.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Platelet-rich plasma can temporarily inhibit some drug-resistant bacteria in diabetic foot infections.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Pegvaliase is recommended for treating adults with phenylketonuria.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.